Skip to main content

Peer Review reports

From: RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity

Original Submission
3 Jul 2022 Submitted Original manuscript
8 Aug 2022 Reviewed Reviewer Report - Seema Chugh
20 Aug 2022 Reviewed Reviewer Report
20 Oct 2022 Author responded Author comments - Sanjeev Gupta
Resubmission - Version 2
20 Oct 2022 Submitted Manuscript version 2
1 Dec 2022 Reviewed Reviewer Report
5 Dec 2022 Reviewed Reviewer Report - Seema Chugh
14 Dec 2022 Author responded Author comments - Sanjeev Gupta
Resubmission - Version 3
14 Dec 2022 Submitted Manuscript version 3
20 Dec 2022 Author responded Author comments - Sanjeev Gupta
Resubmission - Version 4
20 Dec 2022 Submitted Manuscript version 4
18 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
16 Mar 2023 Editorially accepted
30 Mar 2023 Article published 10.1186/s12885-023-10745-1

You can find further information about peer review here.

Back to article page